This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Edward’s Syndrome Treatment Market

Market Insights on Edward’s Syndrome Treatment covering sales outlook, demand forecast & up-to-date key trends

Edward’s Syndrome Treatment Market by Types, Treatment, End User & Region | Forecast 2023 to 2033

Edward’s Syndrome Treatment Market (2023 to 2033)

The global Edward’s syndrome treatment market is expected to garner a market value of US$ 4.9 Billion in 2023 and is expected to accumulate a market value of US$ 7.98 Billion by registering a CAGR of 5% in the forecast period 2023 to 2033. The growth of Edward’s syndrome treatment market can be attributed to an increase in investment in research and development. The market for Edward’s syndrome registered a CAGR of 3% in the historical period 2018 to 2022

Edwards syndrome, also known as Trisomy 18, is a chromosomal disorder that occurs in about 1 in 5,000 live births. The condition is characterized by severe intellectual disability and physical abnormalities, and many affected infants do not survive beyond the first few months of life.

It is possible that with the advancement of medical technology, doctors are now able to diagnose Edwards syndrome more accurately and earlier in pregnancy, which may lead to an increase in demand for treatment. Additionally, with the increasing popularity of genetic testing, more families may be learning about the diagnosis in their family, leading to more demand for treatment.

Report Attribute

Details

Expected Market Value (2023)

US$ 4.9 Billion

Anticipated Forecast Value (2033)

US$ 7.98 Billion

Projected Growth Rate (2023 to 2033)

5% CAGR

Customize this Report

Let us know your requirement to get
100% FREE customization

2018 to 2022 Edward’s Syndrome Treatment Market Demand Analysis vs. Forecast 2023 to 2033

According to market research and competitive intelligence provider Future Market Insights- the market for Edward’s syndrome treatment reflected a value of 3% during the historical period, 2018 to 2022.

Treatment for Edwards syndrome focuses mainly on addressing the symptoms and complications that result from the condition. There is no cure for Edwards syndrome, and treatment is supportive in nature. It usually involves a team of healthcare professionals such as physicians, nurses, genetic counselors, occupational therapists, physical therapists, speech therapists, and social workers to provide comprehensive care. The focus is on providing medical care and support to the affected individual and their families in order to improve their quality of life. Treatments may include surgery, physiotherapy, speech therapy, and support for developmental milestones.

Thus, the market for Edward’s syndrome treatment is expected to register a CAGR of 5% in the forecast period 2023 to 2033.

Which are Some Prominent Drivers of Edward’s Syndrome Treatment Market?

Improved healthcare infrastructure and government initiatives supporting market growth

The rapid rise in cases of central nervous system disorder is expected to accelerate the market growth in the forecast period of 2023 to 2033. Likewise, the increase in the occurrence of Edwards syndrome and rise in the healthcare spending is also predictable to enhance the Edwards syndrome treatment market growth. Furthermore, the increased government support and the rise in genetic counseling are also projected to drive the market growth rate.

In addition, the technological advancements for effective treatment and the easy availability of advanced healthcare facilities are likely to create various new opportunities that will impact this Edwards syndrome market growth in the forecast period of 2023 to 2033.

The availability of various treatments creates lucrative opportunities for the Edwards syndrome market

Treatment for Edwards syndrome primarily focuses on managing the symptoms and complications that arise from the condition.

Prenatal care: when a fetus is diagnosed with Edwards syndrome, regular prenatal care can help monitor the baby's growth and development, as well as prepare for the delivery and care of the baby after birth.

Medical management: infants with Edwards syndrome often have a range of medical issues that need to be addressed, such as heart defects, respiratory problems, and feeding difficulties. Treatment may involve surgery, medication, and other therapies to address these issues.

Supportive care: infants with Edwards syndrome will require extensive care and support to address their physical and intellectual disabilities. This may include physical therapy, occupational therapy, speech therapy, and other forms of rehabilitation to help them reach their full potential.

Genetic counseling: for families who have a child with Edwards syndrome, genetic counseling may be recommended to help them understand the condition and the risks of recurrence in future

Sabyasachi Ghosh
Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

What are the Challenges Faced by the Edward’s Syndrome Treatment Market?

Lack of awareness and failure of treatment hindering the overall market growth

The high treatment cost and lack of awareness about the treatment are expected to act as major restraints towards the growth of the Edwards syndrome market, whereas lack of awareness amongst patients can challenge the growth of the target market in the above-mentioned forecast period.

Certain treatments may improve some of the symptoms, but they do not cure the underlying genetic problem. Even with the best care, most infants with Edwards syndrome do not survive past their first year of life. Thus, all these factors are hampering the growth of the overall market.

Region-Wise Insights

Advancement in Prenatal Screening for Treating Edwards Syndrome Bolstering Market Growth in North America?

Government-based foundations help families to understand Edwards syndrome better

In North America prenatal screening is offered to all pregnant women as part of their routine care. The screening allows for the identification of fetuses at increased risk of chromosomal disorders such as Edward syndrome, where then follow-up diagnostic tests, such as chorionic villus sampling or amniocentesis, can confirm or exclude the diagnosis. With the advancement of prenatal screening and diagnostic technologies, doctors are now able to diagnose Edwards syndrome more accurately and earlier in pregnancy which could lead to an increase in demand for treatment.

It's worth mentioning that, in North America, there are also a number of organizations that provide support and resources for families affected by Edwards syndrome, such as the Trisomy 18 Foundation. These organizations can help families connect with others who have experience with the condition, learn about treatments and resources, and advocate for their loved one's care.

Thus, North America is expected to possess a 45% market share of the Edwards syndrome treatment market in 2023.

Increasing Access to Better Healthcare Improving Treatment for Edwards Syndrome Market in the Asia Pacific?

Integration of technology offering better results for diagnostic tests

Healthcare systems and resources vary greatly across the countries and regions of Asia Pacific, especially in China, India, and Japan. This, in turn, has created wide availability and accessibility of treatments for Edwards syndrome in the region. With increasing access to better healthcare resources and genetic screening techniques, the diagnostics and treatments for Edwards Syndrome are expected to improve in the region.

Furthermore, the presence of well-developed healthcare infrastructure and favorable government support. Thus, Asia Pacific is expected to hold a 39% market share for Edwards syndrome treatment in 2023.

MarketNage
Become a MarketNgage Insider

A unified Market Research Subscription Platform, built for today's disparate research needs.

Category-Wise Insights

Availability of Various Treatments Making Hospitals Convenient for Treatment for Edward’s Syndrome Treatment Market?

Favorable reimbursement policies make hospitals a viable option for treatment

On the basis of end-user, the Edwards syndrome treatment market is segmented into Hospitals, Clinics, Ambulatory Surgical Centres, Others

The hospital segment is expected to hold the largest market share for Edward’s syndrome treatment. This is owing to the availability of various treatments and diagnostics in hospitals. In addition, the presence of healthcare experts and cardiologists is playing a key role in the wide usage of hospitals for the treatment of Edward’s syndrome treatment.

Furthermore, initiatives by government authorities to support the treatment of Edward’s syndrome treatment, especially in hospitals are favoring the growth of the same. Moreover, reimbursement schemes and their benefits are making hospitals a go-to option for the treatment of Edward’s syndrome treatment. Thus, hospitals are expected to hold a 40% market share of Edward’s syndrome treatment market in 2023.

Market Competition

Key players in the Edwards syndrome treatment market are Merck & Co, Kyorin Pharmaceuticals, Pfizer Inc, Bellus Health, Eli Lilly and Company, GeneScience Pharmaceuticals Co., Ltd, Johnson & Johnson Private Limited, Teva Pharmaceutical Industries Ltd, Sanofi, Bayer AG

  • Sanofi, a key player in the Edwards syndrome treatment market is focusing on integrating technology to offer diagnostic tests for treating Edwards syndrome treatment.
  • Johnson & Johnson Private Limited, another key player in the Edwards syndrome treatment market is focusing on investing in research and development for innovating medications.

Report Scope

Report Attribute

Details

Market Value in 2023

US$ 4.9 Billion

Market Value in 2033

US$ 7.98 Billion

Growth Rate

CAGR of 5% from 2023 to 2033

Base Year for Estimation

2022

Historical Data

2018 to 2022

Forecast Period

2023 to 2033

Quantitative Units

Revenue in USD Billion and CAGR from 2023 to 2033

Report Coverage

Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis

Segments Covered

  • Types
  • Treatment
  • End User
  • Region

Regions Covered

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa (MEA)

Key Countries Profiled

  • United States of America
  • Canada
  • Brazil
  • Argentina
  • Germany
  • United Kingdom
  • France
  • Spain
  • Italy
  • Nordics
  • BENELUX
  • Australia & New Zealand
  • China
  • India
  • Association of Southeast Asian Nations (ASEAN)
  • GCC
  • South Africa

Key Companies Profiled

  • Merck & Co
  • Kyorin Pharmaceuticals
  • Pfizer Inc
  • Bellus Health
  • Eli Lilly and Company
  • GeneScience Pharmaceuticals Co., Ltd
  • Johnson & Johnson Private Limited
  • Teva Pharmaceutical Industries Ltd
  • Sanofi
  • Bayer AG

Customization

Available Upon Request

Key Segments Profiled in the Edward’s Syndrome Treatment Industry Survey

Types:

  • Full Trisomy 18
  • Mosaic Trisomy 18
  • Partial Trisomy 18

Treatment:

  • Cardiac Treatment
  • Assisted Feeding
  • Orthopaedic Treatment
  • Psychosocial Support
  • Others

End User:

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centres
  • Others

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa (MEA)

Frequently Asked Questions

From 2018-2022, the Edward’s syndrome treatment market grew at a CAGR of 3%

The global Edward’s syndrome treatment market is expected to grow with a 5% CAGR during 2023 to 2033.

As of 2033, the Edward’s syndrome treatment market is expected to reach US$ 7.98 Billion

Hospitals are expected to hold 40% of the market share in 2023 for Edward’s syndrome treatment market.

North America is expected to possess 45% market share for Edward’s syndrome treatment market in 2023.

Asia Pacific Edward’s syndrome treatment market size is expected to possess 39% market share in 2023.

Table of Content

1. Executive Summary | Edward’s Syndrome Treatment Market

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Investment Feasibility Matrix

    3.5. PESTLE and Porter’s Analysis

    3.6. Regulatory Landscape

        3.6.1. By Key Regions

        3.6.2. By Key Countries

    3.7. Regional Parent Market Outlook

4. Global Market Analysis 2018-2022 and Forecast, 2023 to 2033

    4.1. Historical Market Size Value (US$ Million) Analysis, 2018-2022

    4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2018-2022 and Forecast 2023 to 2033, By Types

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Million) Analysis By Types, 2018-2022

    5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Types, 2023 to 2033

        5.3.1. Full Trisomy 18

        5.3.2. Mosaic Trisomy 18

        5.3.3. Partial Trisomy 18

    5.4. Y-o-Y Growth Trend Analysis By Types, 2018-2022

    5.5. Absolute $ Opportunity Analysis By Types, 2023 to 2033

6. Global Market Analysis 2018-2022 and Forecast 2023 to 2033, By Treatment

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Million) Analysis By Treatment, 2018-2022

    6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Treatment, 2023 to 2033

        6.3.1. Cardiac Treatment

        6.3.2. Assisted Feeding

        6.3.3. Orthopaedic Treatment

        6.3.4. Psychosocial Support

        6.3.5. Others

    6.4. Y-o-Y Growth Trend Analysis By Treatment, 2018-2022

    6.5. Absolute $ Opportunity Analysis By Treatment, 2023 to 2033

7. Global Market Analysis 2018-2022 and Forecast 2023 to 2033, By End-user

    7.1. Introduction / Key Findings

    7.2. Historical Market Size Value (US$ Million) Analysis By End-user, 2018-2022

    7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End-user, 2023 to 2033

        7.3.1. Hospitals

        7.3.2. Clinics

        7.3.3. Ambulatory Surgical Centres

        7.3.4. Others

    7.4. Y-o-Y Growth Trend Analysis By End-user, 2018-2022

    7.5. Absolute $ Opportunity Analysis By End-user, 2023 to 2033

8. Global Market Analysis 2018-2022 and Forecast 2023 to 2033, By Region

    8.1. Introduction

    8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018-2022

    8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033

        8.3.1. North America

        8.3.2. Latin America

        8.3.3. Europe

        8.3.4. South Asia

        8.3.5. East Asia

        8.3.6. Oceania

        8.3.7. Middle East & Africa (MEA)

    8.4. Market Attractiveness Analysis By Region

9. North America Market Analysis 2018-2022 and Forecast 2023 to 2033, By Country

    9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018-2022

    9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        9.2.1. By Country

            9.2.1.1. USA

            9.2.1.2. Canada

        9.2.2. By Types

        9.2.3. By Treatment

        9.2.4. By End-user

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Types

        9.3.3. By Treatment

        9.3.4. By End-user

    9.4. Key Takeaways

10. Latin America Market Analysis 2018-2022 and Forecast 2023 to 2033, By Country

    10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018-2022

    10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        10.2.1. By Country

            10.2.1.1. Brazil

            10.2.1.2. Mexico

            10.2.1.3. Rest of Latin America

        10.2.2. By Types

        10.2.3. By Treatment

        10.2.4. By End-user

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Types

        10.3.3. By Treatment

        10.3.4. By End-user

    10.4. Key Takeaways

11. Europe Market Analysis 2018-2022 and Forecast 2023 to 2033, By Country

    11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018-2022

    11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        11.2.1. By Country

            11.2.1.1. Germany

            11.2.1.2. UK

            11.2.1.3. France

            11.2.1.4. Spain

            11.2.1.5. Italy

            11.2.1.6. Rest of Europe

        11.2.2. By Types

        11.2.3. By Treatment

        11.2.4. By End-user

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Types

        11.3.3. By Treatment

        11.3.4. By End-user

    11.4. Key Takeaways

12. South Asia Market Analysis 2018-2022 and Forecast 2023 to 2033, By Country

    12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018-2022

    12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        12.2.1. By Country

            12.2.1.1. India

            12.2.1.2. Malaysia

            12.2.1.3. Singapore

            12.2.1.4. Thailand

            12.2.1.5. Rest of South Asia

        12.2.2. By Types

        12.2.3. By Treatment

        12.2.4. By End-user

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Types

        12.3.3. By Treatment

        12.3.4. By End-user

    12.4. Key Takeaways

13. East Asia Market Analysis 2018-2022 and Forecast 2023 to 2033, By Country

    13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018-2022

    13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        13.2.1. By Country

            13.2.1.1. China

            13.2.1.2. Japan

            13.2.1.3. South Korea

        13.2.2. By Types

        13.2.3. By Treatment

        13.2.4. By End-user

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Types

        13.3.3. By Treatment

        13.3.4. By End-user

    13.4. Key Takeaways

14. Oceania Market Analysis 2018-2022 and Forecast 2023 to 2033, By Country

    14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018-2022

    14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        14.2.1. By Country

            14.2.1.1. Australia

            14.2.1.2. New Zealand

        14.2.2. By Types

        14.2.3. By Treatment

        14.2.4. By End-user

    14.3. Market Attractiveness Analysis

        14.3.1. By Country

        14.3.2. By Types

        14.3.3. By Treatment

        14.3.4. By End-user

    14.4. Key Takeaways

15. MEA Market Analysis 2018-2022 and Forecast 2023 to 2033, By Country

    15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018-2022

    15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        15.2.1. By Country

            15.2.1.1. GCC Countries

            15.2.1.2. South Africa

            15.2.1.3. Israel

            15.2.1.4. Rest of MEA

        15.2.2. By Types

        15.2.3. By Treatment

        15.2.4. By End-user

    15.3. Market Attractiveness Analysis

        15.3.1. By Country

        15.3.2. By Types

        15.3.3. By Treatment

        15.3.4. By End-user

    15.4. Key Takeaways

16. Key Countries Market Analysis

    16.1. USA

        16.1.1. Pricing Analysis

        16.1.2. Market Share Analysis, 2022

            16.1.2.1. By Types

            16.1.2.2. By Treatment

            16.1.2.3. By End-user

    16.2. Canada

        16.2.1. Pricing Analysis

        16.2.2. Market Share Analysis, 2022

            16.2.2.1. By Types

            16.2.2.2. By Treatment

            16.2.2.3. By End-user

    16.3. Brazil

        16.3.1. Pricing Analysis

        16.3.2. Market Share Analysis, 2022

            16.3.2.1. By Types

            16.3.2.2. By Treatment

            16.3.2.3. By End-user

    16.4. Mexico

        16.4.1. Pricing Analysis

        16.4.2. Market Share Analysis, 2022

            16.4.2.1. By Types

            16.4.2.2. By Treatment

            16.4.2.3. By End-user

    16.5. Germany

        16.5.1. Pricing Analysis

        16.5.2. Market Share Analysis, 2022

            16.5.2.1. By Types

            16.5.2.2. By Treatment

            16.5.2.3. By End-user

    16.6. UK

        16.6.1. Pricing Analysis

        16.6.2. Market Share Analysis, 2022

            16.6.2.1. By Types

            16.6.2.2. By Treatment

            16.6.2.3. By End-user

    16.7. France

        16.7.1. Pricing Analysis

        16.7.2. Market Share Analysis, 2022

            16.7.2.1. By Types

            16.7.2.2. By Treatment

            16.7.2.3. By End-user

    16.8. Spain

        16.8.1. Pricing Analysis

        16.8.2. Market Share Analysis, 2022

            16.8.2.1. By Types

            16.8.2.2. By Treatment

            16.8.2.3. By End-user

    16.9. Italy

        16.9.1. Pricing Analysis

        16.9.2. Market Share Analysis, 2022

            16.9.2.1. By Types

            16.9.2.2. By Treatment

            16.9.2.3. By End-user

    16.10. India

        16.10.1. Pricing Analysis

        16.10.2. Market Share Analysis, 2022

            16.10.2.1. By Types

            16.10.2.2. By Treatment

            16.10.2.3. By End-user

    16.11. Malaysia

        16.11.1. Pricing Analysis

        16.11.2. Market Share Analysis, 2022

            16.11.2.1. By Types

            16.11.2.2. By Treatment

            16.11.2.3. By End-user

    16.12. Singapore

        16.12.1. Pricing Analysis

        16.12.2. Market Share Analysis, 2022

            16.12.2.1. By Types

            16.12.2.2. By Treatment

            16.12.2.3. By End-user

    16.13. Thailand

        16.13.1. Pricing Analysis

        16.13.2. Market Share Analysis, 2022

            16.13.2.1. By Types

            16.13.2.2. By Treatment

            16.13.2.3. By End-user

    16.14. China

        16.14.1. Pricing Analysis

        16.14.2. Market Share Analysis, 2022

            16.14.2.1. By Types

            16.14.2.2. By Treatment

            16.14.2.3. By End-user

    16.15. Japan

        16.15.1. Pricing Analysis

        16.15.2. Market Share Analysis, 2022

            16.15.2.1. By Types

            16.15.2.2. By Treatment

            16.15.2.3. By End-user

    16.16. South Korea

        16.16.1. Pricing Analysis

        16.16.2. Market Share Analysis, 2022

            16.16.2.1. By Types

            16.16.2.2. By Treatment

            16.16.2.3. By End-user

    16.17. Australia

        16.17.1. Pricing Analysis

        16.17.2. Market Share Analysis, 2022

            16.17.2.1. By Types

            16.17.2.2. By Treatment

            16.17.2.3. By End-user

    16.18. New Zealand

        16.18.1. Pricing Analysis

        16.18.2. Market Share Analysis, 2022

            16.18.2.1. By Types

            16.18.2.2. By Treatment

            16.18.2.3. By End-user

    16.19. GCC Countries

        16.19.1. Pricing Analysis

        16.19.2. Market Share Analysis, 2022

            16.19.2.1. By Types

            16.19.2.2. By Treatment

            16.19.2.3. By End-user

    16.20. South Africa

        16.20.1. Pricing Analysis

        16.20.2. Market Share Analysis, 2022

            16.20.2.1. By Types

            16.20.2.2. By Treatment

            16.20.2.3. By End-user

    16.21. Israel

        16.21.1. Pricing Analysis

        16.21.2. Market Share Analysis, 2022

            16.21.2.1. By Types

            16.21.2.2. By Treatment

            16.21.2.3. By End-user

17. Market Structure Analysis

    17.1. Competition Dashboard

    17.2. Competition Benchmarking

    17.3. Market Share Analysis of Top Players

        17.3.1. By Regional

        17.3.2. By Types

        17.3.3. By Treatment

        17.3.4. By End-user

18. Competition Analysis

    18.1. Competition Deep Dive

        18.1.1. Merck & Co

            18.1.1.1. Overview

            18.1.1.2. Product Portfolio

            18.1.1.3. Profitability by Market Segments

            18.1.1.4. Sales Footprint

            18.1.1.5. Strategy Overview

                18.1.1.5.1. Marketing Strategy

        18.1.2. Kyorin Pharmaceuticals

            18.1.2.1. Overview

            18.1.2.2. Product Portfolio

            18.1.2.3. Profitability by Market Segments

            18.1.2.4. Sales Footprint

            18.1.2.5. Strategy Overview

                18.1.2.5.1. Marketing Strategy

        18.1.3. Pfizer Inc.

            18.1.3.1. Overview

            18.1.3.2. Product Portfolio

            18.1.3.3. Profitability by Market Segments

            18.1.3.4. Sales Footprint

            18.1.3.5. Strategy Overview

                18.1.3.5.1. Marketing Strategy

        18.1.4. Bellus Health

            18.1.4.1. Overview

            18.1.4.2. Product Portfolio

            18.1.4.3. Profitability by Market Segments

            18.1.4.4. Sales Footprint

            18.1.4.5. Strategy Overview

                18.1.4.5.1. Marketing Strategy

        18.1.5. Eli Lilly and Company

            18.1.5.1. Overview

            18.1.5.2. Product Portfolio

            18.1.5.3. Profitability by Market Segments

            18.1.5.4. Sales Footprint

            18.1.5.5. Strategy Overview

                18.1.5.5.1. Marketing Strategy

        18.1.6. GeneScience Pharmaceuticals Co., Ltd.

            18.1.6.1. Overview

            18.1.6.2. Product Portfolio

            18.1.6.3. Profitability by Market Segments

            18.1.6.4. Sales Footprint

            18.1.6.5. Strategy Overview

                18.1.6.5.1. Marketing Strategy

        18.1.7. Johnson & Johnson Private Limited

            18.1.7.1. Overview

            18.1.7.2. Product Portfolio

            18.1.7.3. Profitability by Market Segments

            18.1.7.4. Sales Footprint

            18.1.7.5. Strategy Overview

                18.1.7.5.1. Marketing Strategy

        18.1.8. Teva Pharmaceutical Industries Ltd.

            18.1.8.1. Overview

            18.1.8.2. Product Portfolio

            18.1.8.3. Profitability by Market Segments

            18.1.8.4. Sales Footprint

            18.1.8.5. Strategy Overview

                18.1.8.5.1. Marketing Strategy

        18.1.9. Sanofi

            18.1.9.1. Overview

            18.1.9.2. Product Portfolio

            18.1.9.3. Profitability by Market Segments

            18.1.9.4. Sales Footprint

            18.1.9.5. Strategy Overview

                18.1.9.5.1. Marketing Strategy

        18.1.10. Bayer AG

            18.1.10.1. Overview

            18.1.10.2. Product Portfolio

            18.1.10.3. Profitability by Market Segments

            18.1.10.4. Sales Footprint

            18.1.10.5. Strategy Overview

                18.1.10.5.1. Marketing Strategy

19. Assumptions & Acronyms Used

20. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 1: Global Market Value (US$ Million) Forecast by Region, 2018 to 2033

Table 2: Global Market Value (US$ Million) Forecast by Types, 2018 to 2033

Table 3: Global Market Value (US$ Million) Forecast by Treatment, 2018 to 2033

Table 4: Global Market Value (US$ Million) Forecast by End-user, 2018 to 2033

Table 5: North America Market Value (US$ Million) Forecast by Country, 2018 to 2033

Table 6: North America Market Value (US$ Million) Forecast by Types, 2018 to 2033

Table 7: North America Market Value (US$ Million) Forecast by Treatment, 2018 to 2033

Table 8: North America Market Value (US$ Million) Forecast by End-user, 2018 to 2033

Table 9: Latin America Market Value (US$ Million) Forecast by Country, 2018 to 2033

Table 10: Latin America Market Value (US$ Million) Forecast by Types, 2018 to 2033

Table 11: Latin America Market Value (US$ Million) Forecast by Treatment, 2018 to 2033

Table 12: Latin America Market Value (US$ Million) Forecast by End-user, 2018 to 2033

Table 13: Europe Market Value (US$ Million) Forecast by Country, 2018 to 2033

Table 14: Europe Market Value (US$ Million) Forecast by Types, 2018 to 2033

Table 15: Europe Market Value (US$ Million) Forecast by Treatment, 2018 to 2033

Table 16: Europe Market Value (US$ Million) Forecast by End-user, 2018 to 2033

Table 17: South Asia Market Value (US$ Million) Forecast by Country, 2018 to 2033

Table 18: South Asia Market Value (US$ Million) Forecast by Types, 2018 to 2033

Table 19: South Asia Market Value (US$ Million) Forecast by Treatment, 2018 to 2033

Table 20: South Asia Market Value (US$ Million) Forecast by End-user, 2018 to 2033

Table 21: East Asia Market Value (US$ Million) Forecast by Country, 2018 to 2033

Table 22: East Asia Market Value (US$ Million) Forecast by Types, 2018 to 2033

Table 23: East Asia Market Value (US$ Million) Forecast by Treatment, 2018 to 2033

Table 24: East Asia Market Value (US$ Million) Forecast by End-user, 2018 to 2033

Table 25: Oceania Market Value (US$ Million) Forecast by Country, 2018 to 2033

Table 26: Oceania Market Value (US$ Million) Forecast by Types, 2018 to 2033

Table 27: Oceania Market Value (US$ Million) Forecast by Treatment, 2018 to 2033

Table 28: Oceania Market Value (US$ Million) Forecast by End-user, 2018 to 2033

Table 29: MEA Market Value (US$ Million) Forecast by Country, 2018 to 2033

Table 30: MEA Market Value (US$ Million) Forecast by Types, 2018 to 2033

Table 31: MEA Market Value (US$ Million) Forecast by Treatment, 2018 to 2033

Table 32: MEA Market Value (US$ Million) Forecast by End-user, 2018 to 2033

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 1: Global Market Value (US$ Million) by Types, 2023 to 2033

Figure 2: Global Market Value (US$ Million) by Treatment, 2023 to 2033

Figure 3: Global Market Value (US$ Million) by End-user, 2023 to 2033

Figure 4: Global Market Value (US$ Million) by Region, 2023 to 2033

Figure 5: Global Market Value (US$ Million) Analysis by Region, 2018 to 2033

Figure 6: Global Market Value Share (%) and BPS Analysis by Region, 2023 to 2033

Figure 7: Global Market Y-o-Y Growth (%) Projections by Region, 2023 to 2033

Figure 8: Global Market Value (US$ Million) Analysis by Types, 2018 to 2033

Figure 9: Global Market Value Share (%) and BPS Analysis by Types, 2023 to 2033

Figure 10: Global Market Y-o-Y Growth (%) Projections by Types, 2023 to 2033

Figure 11: Global Market Value (US$ Million) Analysis by Treatment, 2018 to 2033

Figure 12: Global Market Value Share (%) and BPS Analysis by Treatment, 2023 to 2033

Figure 13: Global Market Y-o-Y Growth (%) Projections by Treatment, 2023 to 2033

Figure 14: Global Market Value (US$ Million) Analysis by End-user, 2018 to 2033

Figure 15: Global Market Value Share (%) and BPS Analysis by End-user, 2023 to 2033

Figure 16: Global Market Y-o-Y Growth (%) Projections by End-user, 2023 to 2033

Figure 17: Global Market Attractiveness by Types, 2023 to 2033

Figure 18: Global Market Attractiveness by Treatment, 2023 to 2033

Figure 19: Global Market Attractiveness by End-user, 2023 to 2033

Figure 20: Global Market Attractiveness by Region, 2023 to 2033

Figure 21: North America Market Value (US$ Million) by Types, 2023 to 2033

Figure 22: North America Market Value (US$ Million) by Treatment, 2023 to 2033

Figure 23: North America Market Value (US$ Million) by End-user, 2023 to 2033

Figure 24: North America Market Value (US$ Million) by Country, 2023 to 2033

Figure 25: North America Market Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 26: North America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 27: North America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 28: North America Market Value (US$ Million) Analysis by Types, 2018 to 2033

Figure 29: North America Market Value Share (%) and BPS Analysis by Types, 2023 to 2033

Figure 30: North America Market Y-o-Y Growth (%) Projections by Types, 2023 to 2033

Figure 31: North America Market Value (US$ Million) Analysis by Treatment, 2018 to 2033

Figure 32: North America Market Value Share (%) and BPS Analysis by Treatment, 2023 to 2033

Figure 33: North America Market Y-o-Y Growth (%) Projections by Treatment, 2023 to 2033

Figure 34: North America Market Value (US$ Million) Analysis by End-user, 2018 to 2033

Figure 35: North America Market Value Share (%) and BPS Analysis by End-user, 2023 to 2033

Figure 36: North America Market Y-o-Y Growth (%) Projections by End-user, 2023 to 2033

Figure 37: North America Market Attractiveness by Types, 2023 to 2033

Figure 38: North America Market Attractiveness by Treatment, 2023 to 2033

Figure 39: North America Market Attractiveness by End-user, 2023 to 2033

Figure 40: North America Market Attractiveness by Country, 2023 to 2033

Figure 41: Latin America Market Value (US$ Million) by Types, 2023 to 2033

Figure 42: Latin America Market Value (US$ Million) by Treatment, 2023 to 2033

Figure 43: Latin America Market Value (US$ Million) by End-user, 2023 to 2033

Figure 44: Latin America Market Value (US$ Million) by Country, 2023 to 2033

Figure 45: Latin America Market Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 46: Latin America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 47: Latin America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 48: Latin America Market Value (US$ Million) Analysis by Types, 2018 to 2033

Figure 49: Latin America Market Value Share (%) and BPS Analysis by Types, 2023 to 2033

Figure 50: Latin America Market Y-o-Y Growth (%) Projections by Types, 2023 to 2033

Figure 51: Latin America Market Value (US$ Million) Analysis by Treatment, 2018 to 2033

Figure 52: Latin America Market Value Share (%) and BPS Analysis by Treatment, 2023 to 2033

Figure 53: Latin America Market Y-o-Y Growth (%) Projections by Treatment, 2023 to 2033

Figure 54: Latin America Market Value (US$ Million) Analysis by End-user, 2018 to 2033

Figure 55: Latin America Market Value Share (%) and BPS Analysis by End-user, 2023 to 2033

Figure 56: Latin America Market Y-o-Y Growth (%) Projections by End-user, 2023 to 2033

Figure 57: Latin America Market Attractiveness by Types, 2023 to 2033

Figure 58: Latin America Market Attractiveness by Treatment, 2023 to 2033

Figure 59: Latin America Market Attractiveness by End-user, 2023 to 2033

Figure 60: Latin America Market Attractiveness by Country, 2023 to 2033

Figure 61: Europe Market Value (US$ Million) by Types, 2023 to 2033

Figure 62: Europe Market Value (US$ Million) by Treatment, 2023 to 2033

Figure 63: Europe Market Value (US$ Million) by End-user, 2023 to 2033

Figure 64: Europe Market Value (US$ Million) by Country, 2023 to 2033

Figure 65: Europe Market Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 66: Europe Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 67: Europe Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 68: Europe Market Value (US$ Million) Analysis by Types, 2018 to 2033

Figure 69: Europe Market Value Share (%) and BPS Analysis by Types, 2023 to 2033

Figure 70: Europe Market Y-o-Y Growth (%) Projections by Types, 2023 to 2033

Figure 71: Europe Market Value (US$ Million) Analysis by Treatment, 2018 to 2033

Figure 72: Europe Market Value Share (%) and BPS Analysis by Treatment, 2023 to 2033

Figure 73: Europe Market Y-o-Y Growth (%) Projections by Treatment, 2023 to 2033

Figure 74: Europe Market Value (US$ Million) Analysis by End-user, 2018 to 2033

Figure 75: Europe Market Value Share (%) and BPS Analysis by End-user, 2023 to 2033

Figure 76: Europe Market Y-o-Y Growth (%) Projections by End-user, 2023 to 2033

Figure 77: Europe Market Attractiveness by Types, 2023 to 2033

Figure 78: Europe Market Attractiveness by Treatment, 2023 to 2033

Figure 79: Europe Market Attractiveness by End-user, 2023 to 2033

Figure 80: Europe Market Attractiveness by Country, 2023 to 2033

Figure 81: South Asia Market Value (US$ Million) by Types, 2023 to 2033

Figure 82: South Asia Market Value (US$ Million) by Treatment, 2023 to 2033

Figure 83: South Asia Market Value (US$ Million) by End-user, 2023 to 2033

Figure 84: South Asia Market Value (US$ Million) by Country, 2023 to 2033

Figure 85: South Asia Market Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 86: South Asia Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 87: South Asia Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 88: South Asia Market Value (US$ Million) Analysis by Types, 2018 to 2033

Figure 89: South Asia Market Value Share (%) and BPS Analysis by Types, 2023 to 2033

Figure 90: South Asia Market Y-o-Y Growth (%) Projections by Types, 2023 to 2033

Figure 91: South Asia Market Value (US$ Million) Analysis by Treatment, 2018 to 2033

Figure 92: South Asia Market Value Share (%) and BPS Analysis by Treatment, 2023 to 2033

Figure 93: South Asia Market Y-o-Y Growth (%) Projections by Treatment, 2023 to 2033

Figure 94: South Asia Market Value (US$ Million) Analysis by End-user, 2018 to 2033

Figure 95: South Asia Market Value Share (%) and BPS Analysis by End-user, 2023 to 2033

Figure 96: South Asia Market Y-o-Y Growth (%) Projections by End-user, 2023 to 2033

Figure 97: South Asia Market Attractiveness by Types, 2023 to 2033

Figure 98: South Asia Market Attractiveness by Treatment, 2023 to 2033

Figure 99: South Asia Market Attractiveness by End-user, 2023 to 2033

Figure 100: South Asia Market Attractiveness by Country, 2023 to 2033

Figure 101: East Asia Market Value (US$ Million) by Types, 2023 to 2033

Figure 102: East Asia Market Value (US$ Million) by Treatment, 2023 to 2033

Figure 103: East Asia Market Value (US$ Million) by End-user, 2023 to 2033

Figure 104: East Asia Market Value (US$ Million) by Country, 2023 to 2033

Figure 105: East Asia Market Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 106: East Asia Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 107: East Asia Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 108: East Asia Market Value (US$ Million) Analysis by Types, 2018 to 2033

Figure 109: East Asia Market Value Share (%) and BPS Analysis by Types, 2023 to 2033

Figure 110: East Asia Market Y-o-Y Growth (%) Projections by Types, 2023 to 2033

Figure 111: East Asia Market Value (US$ Million) Analysis by Treatment, 2018 to 2033

Figure 112: East Asia Market Value Share (%) and BPS Analysis by Treatment, 2023 to 2033

Figure 113: East Asia Market Y-o-Y Growth (%) Projections by Treatment, 2023 to 2033

Figure 114: East Asia Market Value (US$ Million) Analysis by End-user, 2018 to 2033

Figure 115: East Asia Market Value Share (%) and BPS Analysis by End-user, 2023 to 2033

Figure 116: East Asia Market Y-o-Y Growth (%) Projections by End-user, 2023 to 2033

Figure 117: East Asia Market Attractiveness by Types, 2023 to 2033

Figure 118: East Asia Market Attractiveness by Treatment, 2023 to 2033

Figure 119: East Asia Market Attractiveness by End-user, 2023 to 2033

Figure 120: East Asia Market Attractiveness by Country, 2023 to 2033

Figure 121: Oceania Market Value (US$ Million) by Types, 2023 to 2033

Figure 122: Oceania Market Value (US$ Million) by Treatment, 2023 to 2033

Figure 123: Oceania Market Value (US$ Million) by End-user, 2023 to 2033

Figure 124: Oceania Market Value (US$ Million) by Country, 2023 to 2033

Figure 125: Oceania Market Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 126: Oceania Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 127: Oceania Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 128: Oceania Market Value (US$ Million) Analysis by Types, 2018 to 2033

Figure 129: Oceania Market Value Share (%) and BPS Analysis by Types, 2023 to 2033

Figure 130: Oceania Market Y-o-Y Growth (%) Projections by Types, 2023 to 2033

Figure 131: Oceania Market Value (US$ Million) Analysis by Treatment, 2018 to 2033

Figure 132: Oceania Market Value Share (%) and BPS Analysis by Treatment, 2023 to 2033

Figure 133: Oceania Market Y-o-Y Growth (%) Projections by Treatment, 2023 to 2033

Figure 134: Oceania Market Value (US$ Million) Analysis by End-user, 2018 to 2033

Figure 135: Oceania Market Value Share (%) and BPS Analysis by End-user, 2023 to 2033

Figure 136: Oceania Market Y-o-Y Growth (%) Projections by End-user, 2023 to 2033

Figure 137: Oceania Market Attractiveness by Types, 2023 to 2033

Figure 138: Oceania Market Attractiveness by Treatment, 2023 to 2033

Figure 139: Oceania Market Attractiveness by End-user, 2023 to 2033

Figure 140: Oceania Market Attractiveness by Country, 2023 to 2033

Figure 141: MEA Market Value (US$ Million) by Types, 2023 to 2033

Figure 142: MEA Market Value (US$ Million) by Treatment, 2023 to 2033

Figure 143: MEA Market Value (US$ Million) by End-user, 2023 to 2033

Figure 144: MEA Market Value (US$ Million) by Country, 2023 to 2033

Figure 145: MEA Market Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 146: MEA Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 147: MEA Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 148: MEA Market Value (US$ Million) Analysis by Types, 2018 to 2033

Figure 149: MEA Market Value Share (%) and BPS Analysis by Types, 2023 to 2033

Figure 150: MEA Market Y-o-Y Growth (%) Projections by Types, 2023 to 2033

Figure 151: MEA Market Value (US$ Million) Analysis by Treatment, 2018 to 2033

Figure 152: MEA Market Value Share (%) and BPS Analysis by Treatment, 2023 to 2033

Figure 153: MEA Market Y-o-Y Growth (%) Projections by Treatment, 2023 to 2033

Figure 154: MEA Market Value (US$ Million) Analysis by End-user, 2018 to 2033

Figure 155: MEA Market Value Share (%) and BPS Analysis by End-user, 2023 to 2033

Figure 156: MEA Market Y-o-Y Growth (%) Projections by End-user, 2023 to 2033

Figure 157: MEA Market Attractiveness by Types, 2023 to 2033

Figure 158: MEA Market Attractiveness by Treatment, 2023 to 2033

Figure 159: MEA Market Attractiveness by End-user, 2023 to 2033

Figure 160: MEA Market Attractiveness by Country, 2023 to 2033

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Short Sleep Syndrome Treatment Market

Published : July 2020

Healthcare

Myelodysplastic Syndrome Treatment Market

Published : May 2018

Healthcare

Carcinoid Syndrome Diarrhea Treatment Market

Published : May 2017

Healthcare

Dry Eye Syndrome Treatment Market

Published : February 2022

Google translate

Edward’s Syndrome Treatment Market